94 followers
RT @oncosis: https://t.co/Klsw7NUcZF CYP2D6, CYP2C9, CYP2C19, G6PD, HLA-B, SLCO1B1, CACNA1S, RYR1, MT-RNR1, and IFNL4 are the top 10 pharma…
RT @oncosis: https://t.co/Klsw7NUcZF CYP2D6, CYP2C9, CYP2C19, G6PD, HLA-B, SLCO1B1, CACNA1S, RYR1, MT-RNR1, and IFNL4 are the top 10 pharma…
https://t.co/Klsw7NUcZF CYP2D6, CYP2C9, CYP2C19, G6PD, HLA-B, SLCO1B1, CACNA1S, RYR1, MT-RNR1, and IFNL4 are the top 10 pharmacogenes, where each is predicted to impact patients' responses to ≥5 drugs. #CancerResearch @ICMRDELHI @DBTIndia @IndiaDST @serbon